FORESITE CAPITAL MANAGEMENT VI LLC 13F Portfolio
FORESITE CAPITAL MANAGEMENT VI LLC runs FORESITE CAPITAL MANAGEMENT VI LLC and currently holds 23 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $642.58M. Their top holdings are CGON, ALMS, SPTX, DNLI, CLDX. The top five represent 61.5% of reported portfolio weight. FORESITE CAPITAL MANAGEMENT VI LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, FORESITE CAPITAL MANAGEMENT VI LLC initiated 7 new positions. They added to 5 existing positions. Their current best-performing preview position is HNGE with returns of +115.25%.
Portfolio Value
$642.58M
Alpha Score
119.1
#0 of 1000
Holdings
23
FORESITE CAPITAL MANAGEMENT VI LLC Current 13F Holdings
Reported holdings from FORESITE CAPITAL MANAGEMENT VI LLC's latest SEC 13F filing, ranked by portfolio weight.
23 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 CGON CG Oncology, Inc. | 26.20% | $31.33 | $63.82 | +103.70% | Added +6.67% |
 ALMS ALUMIS INC. | 18.60% | $7.81 | $7.16 | -8.32% | Held |
SP SPTX Seaport Therapeutics, Inc. | 6.01% | $21.72 | $18.15 | -16.44% | New Buy |
 DNLI Denali Therapeutics Inc. | 5.59% | $16.72 | $19.45 | +16.33% | Added +15.44% |
 CLDX Celldex Therapeutics, Inc. | 5.09% | $35.24 | $29.89 | -15.18% | Added +178.47% |
 AGIO AGIOS PHARMACEUTICALS, INC. | 4.53% | $30.50 | $31.81 | +4.30% | Added +49.52% |
 CRVS Corvus Pharmaceuticals, Inc. | 4.26% | $7.54 | $10.52 | +39.52% | Held |
AA AADX Parabilis Medicines, Inc. | 4.26% | $22.78 | $11.46 | -49.69% | New Buy |
 JBIO Jade Biosciences, Inc. | 3.07% | $19.27 | $14.39 | -25.32% | Added +177.08% |
 HNGE Hinge Health, Inc. | 2.85% | $46.64 | $102.89 | +120.60% | Held |
Showing 1-10 of 23